Analysis of IGF2 gene imprinting in breast and colorectal cancer by allele specific-PCR

Journal of Pathology

Volumn 187, Issue 5, 1999, Pages 518-522

  Yun, Kankatsu ^a   Soejima, Hidenobu ^a   Merrie, Arend E H ^a   McCall, John L ^b   Reeve, Anthony E ^c  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Allele specific PCR; Exon connection PCR; Genomic imprinting; Human cancer; IGF2

Indexed keywords

RNA; SOMATOMEDIN;

ALLELE; ARTICLE; BREAST CANCER; COLORECTAL CANCER; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENOME IMPRINTING; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SPECIFICITY;

ALLELES; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; DNA PRIMERS; EXONS; FEMALE; GENOMIC IMPRINTING; GENOTYPE; HUMANS; INSULIN-LIKE GROWTH FACTOR II; MALE; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM;

EID: 0033037809     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199904)187:5<518::AID-PATH276>3.0.CO;2-3     Document Type: Article

References (29)

1. Davies SM. Developmental regulation of genomic imprinting of the IGF2 gene in human liver. Cancer Res 1994; 54: 2560-2562.
2. Ohlsson R, Hedborg F, Holmgren L, Walsh C, Ekström TJ. Overlapping patterns of IGF2 and H19 expression during human development: biallelic IGF2 expression correlates with a lack of H19 expression. Development 1994; 120: 361-368.
3. DeChiara TM, Robertson EJ, Efstratiadis A. Parental imprinting of the mouse insulin-like growth factor II gene. Cell 1964; 849: 859.
4. Rainier S, Johnson LA, Dobry CJ, Ping AJ, Grundy PE, Feinberg AP. Relaxation of printed genes in human cancer. Nature 1993; 362: 747-749.
5. Ogawa O, Eccles MR, Szeto J, et al. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature 1993; 362: 749-751.
6. Suzuki H, Ueda R, Takahashi T. Altered imprinting in lung cancer. Nature Genet 1994; 6: 332-333.
7. Zhan S, Shapiro DN, Helman LJ. Activation of an imprinted allele of the insulin-like growth factor II gene implicated in the rhabdomyosarcoma. J Clin Invest 1994; 94: 445-448.
8. Rainier S, Dobry CJ, Feinberg AP. Loss of imprinting in hepatoblastoma. Cancer Res 1995; 55: 1836-1838.
9. Vu TH, Yballe C, Boonyanit S, Hoffman AR. Insulin-like growth factor II in uterine smooth-muscle tumors: maintenance of genomic imprinting in leiomyomata and loss of imprinting in leiomyosarcomata. J Clin Endocrinol Metab 1995; 80: 1670-1676.
10. Wada M, Seeger RC, Mizoguchi H, Koeffler HP. Maintenance of normal imprinting of H19 and IGF2 genes in neuroblastoma. Cancer Res 1995; 55: 3386-3388.
11. Zhan S, Shapiro DN, Helman LJ. Loss of imprinting of IGF2 in Ewing's sarcoma. Oncogene 1995; 11: 2503-2507.
12. Doucrasy S, Barrois M, Fogel S, et al. High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethytation of H19. Oncogene 1996; 12: 423-430.
13. Kinouchi Y, Hiwatashi N, Higashioka S, Nagashima F, Chida M, Toyota T. Relaxation of imprinting of the insulin-like growth factor II gene in colorectal cancer. Cancer Lett 1996; 107: 105-108.
14. McCann AH, Miller N, O'Meara A, et al. Biallelic expression of the IGF2 gene in human breast disease. Hum Mol Genet 1996; 5: 1123-1127.
15. Mori M, Inoue H, Shiraishi T, et al. Relaxation of insulin-like growth factor 2 imprinting in esophageal cancer. Int J Cancer 1996; 68: 441-446.
16. Rachmilewitz J, Elkin M, Looijenga LHJ, et al. Characterization of the imprinted IPW gene: allelic expression in normal and tumorigenic human tissues. Oncogene 1996; 13: 1687-1692.
17. Uyeno S, Aoki Y, Nata M, et al. IGF2 but not H19 shows loss of imprinting in human glioma. Cancer Res 1996; 56: 5356-5359.
18. Vu TH, Hoffman A. Alterations in the promoter-specific imprinting of the insulin-like growth factor-II gene in Wilms' tumor. J Biol Chem 1996; 271: 9014-9023.
19. Wang DH, Duan JX, Vu TH, Hoffman AR. Increased expression of the insulin-like growth factor-II gene in Wilms' tumor is not dependent on loss of genomic imprinting or loss of heterozygosity. J Biol Chem 1996; 271: 863-870.
20. Yballe C, Vu TH, Hoffman AR. Imprinting and expression of insulin like growth factor-II and H19 in normal breast tissue and breast tumor. J Clin Endocrinol Metab 1996; 81: 1607-1612.
21. Wu HK, Weksberg R, Minden MD, Squire JA. Loss of imprinting of human insulin-like growth factor II gene, IGF2, in acute myeloid leukemia. Biochem Biophys Res Commun 1997; 231: 466-472.
22. Wu HK, Squire JA, Catzavelos CG, Weksberg R. Relaxation of imprinting of human insulin-like growth factor II gene, IGF2, in sporadic breast carcinomas. Biochem Biophys Res Commun 1997; 235: 123-129.
23. Casola S, Pedone PV, Cavazzana AO, et al. Expression and parental imprinting of the H19 gene in human rhabdomyosarcoma. Oncogene 1997; 14: 1503-1510.
24. Soejima H, Yun K. Allele specific-PCR: a novel method for investigation of the imprinted IGF2 gene. Lab Invest 1998; 78: 641-642.
25. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
26. Yun K, Fukumoto M, Jinno Y. Monoallelic expression of the insulin-like growth factor 2 gene in ovarian cancer. Am J Pathol 1996; 148: 1081-1087.
27. Lambert S, Vivario J, Boniver J, Gol-Winkler R. Abnormal expression and structural modification of the insulin-like growth-factor-II gene in human colorectal tumors. Int J Cancer 1990; 46: 405-410.
28. Lamonerie T, Lavialle C, de Galle B, Binoux M, Brison O. Constitutive or inducible overexpression of the IGF-2 gene in cells of a human colon carcinoma cell line. Exp Cell Res 1995; 216: 342-351.
29. Gryfe R, Swallow C, Bapat B, Redston M, Gallinger S, Couture J. Molecular biology of colorectal cancer. Curr Prob Cancer 1997; 21: 233-300.